Immune Complex Assays: Diagnostic and Clinical Application

References

• Theofilopoulos A. N., Dixon F. J. The biology and detection of immune complexes. Adv. Immunol. 1979; 28: 89
   PubMedGoogle Scholar
• Jones V. E., Orlans E. Isolation of immune complexes and characterization of their constituent antigens and antibodies in some human diseases: a review. J. Immunol. Methods 1981; 44: 249
   PubMedGoogle Scholar
• Agnello V. Immune complex assays in rheumatic diseases. Human Pathol. 1983; 14: 343
   PubMed Web of Science ®Google Scholar
• Nydegger V. E., Davis J. S. Soluble immune complexes in human disease. CRC Crit. Rev. Clin. Lab. Sci. 1980; 12: 123
   PubMed Web of Science ®Google Scholar
• Endo L., Corman L. C., Panush R. S. Clinical utility of assays for circulating immune complexes. Med. Clin. N. Amer. 1985; 69: 623
   PubMedGoogle Scholar
• Virella G., Shuler C. W., Sherwood T. Non-complement dependent adsorption of soluble immune complexes to human red cells. Clin. Exp. Immunol. 1983; 54: 448
   PubMedGoogle Scholar
• Theofilopoulos A. N., Dixon F. J. Immune complexes in human diseases. Amer. J. Pathol. 1980; 100: 531
   Web of Science ®Google Scholar
• Williams R. C. Immune Complexes in Clinical and Experimental Medicine. Harvard University Press, Cambridge, MA 1980
   Google Scholar
• Barnett E. V., Knutson D. W., Abrass C. K., Chia D. S., Young L. S., Liebling M. R. Circulating immune complexes: their immunochemistry, detection and importance. Ann. Int. Med. 1979; 91: 430
   PubMed Web of Science ®Google Scholar
• Plotz P. H. Studies of immune complexes. Arth. Rheum. 1982; 25: 1151
   PubMedGoogle Scholar
• Kilpatrick D. C., Weston J. Immune complex assays and their limitations. Med. Lab. Sci. 1985; 42: 178
   PubMedGoogle Scholar
• Schifferli J. A., Ng Y. C., Peters D. K. The role of complement and its receptor in the elimination of immune complexes. N. Engl. J. Med. 1986; 312: 488
   Google Scholar
• van Sulli M. M. O., Amos N., Williams B. D. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor. Ann. Rheum. Dis. 1988; 47: 675
   PubMedGoogle Scholar
• Schifferli J. A., Steiger G., Hauptmann G., Spaeth P. J., Sjoholm A. G. Formation of soluble immune complexes by complement in sera of patients with various hypocomple-mentemic states: difference between inhibition of immune precipitation and solubilization. J. Clin. Invest. 1985; 76: 2127
   PubMedGoogle Scholar
• Medof M. E., Iida K., Mold C., Nussenweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 1982; 156: 1739
   PubMed Web of Science ®Google Scholar
• Medof M. E., Prince G. M. Immune complex alterations occur on the human red cell membrane. Immunology 1983; 50: 11
   PubMedGoogle Scholar
• Griffin F. M. Effects of soluble immune complexes on Fc receptor and C3b receptor-mediated phagocytosis by macrophages. J. Exp. Med. 1980; 152: 905
   PubMed Web of Science ®Google Scholar
• Muller-Eberhard H. J., Calcott M. A. Interaction between Clq and G-globulin. Immunochemistry 1966; 3: 500
   Google Scholar
• Phillips T. M., Holohan T. V., Korec S., More N. S., Queen W. D. The pathophysiology of circulating immune complexes: their role in host-tumor interactions and removal by immunoadsorption therapy. Contemp. TopicsImmunobiol. 1985; 15: 111
   PubMedGoogle Scholar
• Ross G. D., Medof M. E. Membrane complement receptors specific for bound fragments of C3. Adv. Immunol 1985; 37: 217
   PubMed Web of Science ®Google Scholar
• Phillips T. M. The biochemistry of the immune response. Dermatologic Immunology and Allergy, J. Stone. C.V. Mosby, St Louis 1985; chap. 7
   Google Scholar
• Eisen V., Smith H. G. Plasma kinin formation by complexes of aggregated gamma globulin and serum proteins. Brit. Med. J. 1963; 51: 328
   Google Scholar
• Davies G. E., Lowe J. S. A permeability factor released from guinea pig serum by antigen-antibody precipitates. Brit. J. Exp. Pathol. 1960; 41: 335
   PubMedGoogle Scholar
• Kaplan A. P., Spragg J., Austen K. F. The bradykinin forming system of man. Biochemistry of the Acute Allergic Reaction, K. F. Austen, E. L. Becker. Blackwell Scientific Publications, Oxford 1971; 279–302
   Google Scholar
• Margaretten W., McKay D. G. The requirement of platelets in the active arthus reaction. Amer. J. Pathol. 1971; 64: 257
   PubMedGoogle Scholar
• Robbins J., Stetson C. A. An effect of antigen- antibody interaction on blood coagulation. J. Exp. Med. 1959; 109: 1
   PubMed Web of Science ®Google Scholar
• Zimmerman T. S. The platelet in complement-blood coagulation interaction. Adv. Biosci. 1974; 2: 1
   Google Scholar
• Wautier J. L., Tobelem G. M., Peltier A. P., Caen J. P. CI and human platelets. II. Detection by immunological methods and role. Immunology 1976; 30: 459
   PubMedGoogle Scholar
• Kekomari R., Kauppinen H.-L., Penttinen I. C., Myllyla G. Interactions of immune complexes and platelets in rabbits immunized with hapten-carrier conjugates. Acta Pathol. Microbiol. Scand. 1977; 85(C)207
   Google Scholar
• Sacher R. A., Phillips T. M., Shashaty G. G., Jacobson R. J., Rath C. E., Lewis M. G. The demonstration of immune complexes in thrombotic thrombocytopenic purpura and the effects of exchange transfusion. Scand. J. Haematol 1980; 24: 373
   Google Scholar
• Zimmerman S. E., Smith F. P., Phillips T. M., Coffey R. J., Schein P. S. Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations. Brit. Med. J. 1982; 284: 1432
   PubMed Web of Science ®Google Scholar
• Cantrell J. E., Phillips T. M., Schein P. S. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J. Clin. Oncol. 1985; 3: 723
   PubMed Web of Science ®Google Scholar
• Porter C. C., Ruley E. J., Luban N. L.C., Phillips T. M., Bock G. H., Salcedo J. R., Fivush B. A. Accelerated recovery from immune-mediated thrombocytopenia with plasmapheresis. Am. J. Med. 1985; 79: 765
   PubMedGoogle Scholar
• Fearon D. T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J. Exp. Med. 1980; 152: 20
   PubMed Web of Science ®Google Scholar
• Fearon D. T. Cellular receptors for fragments of the third component of complement, Immunol. Today 1984; 5: 105
   Google Scholar
• Taylor R. P., Horgan C., Hooper M., Burge J. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes: in vitro studies and potential general application to clinical immune complex testing. J. Clin. Invest. 1985; 75: 102
   PubMedGoogle Scholar
• Aikawa T., Mitamure T., Tanimoto K., Horiudri Y. Detection of circulating immune complexes by using human red blood cells. J. Lab. Clin. Med. 1979; 94: 902
   PubMed Web of Science ®Google Scholar
• Cornacoff J. B., Zager R. A., Herbert L. A. Mechanisms of binding of immune complexes to human erythrocytes. Clin. Res. 1981; 29: 364A
   Google Scholar
• Cornacoff J. B., Hebert L. A., Smead W. L., VanAman M. E., Birmingham D. J., Waxmann F. J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 1983; 71: 236
   PubMed Web of Science ®Google Scholar
• Siegel I., Liu T. L., Gleicher N. The red-cell immune system. Lancet 1981; 2: 556
   PubMedGoogle Scholar
• Frank M. M. (moderator), Immunoglobulin Fc receptor function activity in autoimmune disease. Ann. Int. Med. 1983; 98: 206
   PubMed Web of Science ®Google Scholar
• Kimberly R. P., Ralph P. Endocytosis by the mononuclear phagocyte system and autoimmune disease. Amer.J. Med. 1983; 74: 481
   PubMedGoogle Scholar
• Brozek C. M., Hoffman C. L., Savage S. M., Searles R. P. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells. Clin. Immunol. Immunopathol. 1988; 46: 299
   PubMedGoogle Scholar
• Ann T. Binding of soluble immune complexes to Fc receptors on human neutrophils - detection by doublecoating indirect rosette formation. Int. Arch. Allergy Appl. Immunol. 1980; 61: 1980
   Google Scholar
• Movat H. Z. Tissue injury and inflammation induced by immune complexes: the critical role of the neutrophil leukocyte. Exp. Mol. Pathol. 1979; 31: 201
   PubMedGoogle Scholar
• Rutherford B., Schenkein H. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes, in vitro. J. Immunol. 1983; 130: 874
   PubMed Web of Science ®Google Scholar
• Natha C. F. Secretory products of macrophages. J. Clin. Invest. 1987; 79: 319
   PubMedGoogle Scholar
• Sinclaire N. R., St C. Immunoregulation by antibody and antigen-antibody immune complexes. Transplant. Proc 1978; 10: 349
   PubMedGoogle Scholar
• Theofilopoulos A. N. Immune complexes in humoral immune responses: suppressive and enhancing effects. Immunol. Today 1980; 1: 1
   PubMedGoogle Scholar
• Uher F., Lamer M. C., Dickler H. B. Antigen-antibody complexes binding to B lymphocyte Fc receptors regulate B lymphocyte differentiation. Cell Immunol. 1985; 95: 368
   PubMedGoogle Scholar
• Hersey P., Murray E., Ruygrok S., Edwards A., Milton G. W. Blocking factors against melanoma line-dependent antibody: relationship to disease activity in melanoma patients. Aust. NZ. J. Surg. 1978; 48: 26
   PubMedGoogle Scholar
• Gauci L., Caraux J., Serrou B. Immune complexes in the context of the immune response in cancer patients. Human Cancer Immunol. 1981; 1: 37
   Google Scholar
• Panayi G. S., Poston R. N., Corrigal V. Inhibition of antibody-mediated lymphocyte cytotoxicity by aggregated human immunoglobulin. Ann. Rheum. Dis. 1977; 36(Suppl)159
   Google Scholar
• Hassner A., Saxon A. Isotype-specific human suppressor T cells for IgE synthesis activated by IgE-anti-IgE immune complexes. J. Immunol. 1986; 132: 2844
   Google Scholar
• Hotta R., Kuriki J., Kakumu S. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases. Clin. Exp. Immunol. 1981; 45: 375
   Google Scholar
• Williams J. D., Smith M. D., Davies B. H. Interaction of immune complexes and T suppressor cells in sarcoidosis. Thorax 1982; 37: 602
   PubMedGoogle Scholar
• Highton J., Panayi G. S., Shepherd P., Wooley P. Effects of sera from patients with rheumatoid arthritis on normal lymphocytes: a possible immunoregulatory role for immune complexes. Ann. Rheum. Dis. 1982; 41: 563
   PubMedGoogle Scholar
• Phillips T. M., McDonald J. S., Lewis M. G. Towards tumor antibody isolation and characterization in immune complexes. Immune Complexes and Plasma Exchanges in Cancer Patients, B. Serrou, C. Rosenfeld. Elsevier/North Holland, Amsterdam 1981; 3
   Google Scholar
• Shin M. L., Gelfand M. C., Nagle R. B., Carlo J. R., Green I., Frank M. M. Localization of receptors for activated complement on visceral epithelial cells of the human renal glomerulus. J. Immunol. 1977; 118: 869
   PubMed Web of Science ®Google Scholar
• Fisher E., Appoy M. D., Cook J., Kazatchkine M. D. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor. J. Immunol. 1986; 136: 1373
   PubMedGoogle Scholar
• Foidart J. B., Salmon J. P., Berthoux F. J., Mathieu P. Binding of soluble immune complexes to human glomerular complement receptors. Kid. Int. 1979; 15: 303
   PubMedGoogle Scholar
• Golbus S. M., Wilson C. B. Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall. Kidney Int. 1979; 16: 148
   PubMedGoogle Scholar
• Gelfand M. C., Frank M. M., Green I., Shin M. L. Binding sites for immune complexes containing IgG in the renal interstitium. Clin. Immunol. Immunopathol. 1979; 13: 19
   PubMedGoogle Scholar
• Braathen L. R., Forre O. T., Husby G., Williams R. C. Evidence for Fc IgG receptors and complement factor C3b receptors in human choroid plexus. Clin. Immunol. Immunopathol. 1979; 14: 284
   PubMedGoogle Scholar
• Peress N. S., Siegelman J., Fleit H. B. High avidity periventricular IgG-Fc receptor activity in human and rabbit brain. Clin. Immunol. Immunopathol. 1987; 42: 229
   PubMedGoogle Scholar
• Matre R., Tonder O., Endresen C. Fc receptors in human placenta. Scand. J. Immunol. 1975; 4: 741
   PubMed Web of Science ®Google Scholar
• Phillips J. O., Komiyama K., Miller Epps J., Russell M. W., Mestecky J. Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice. Mol. Immunol. 1988; 25: 873
   PubMedGoogle Scholar
• Rifai A., Mannik M. Clearance kinetics and fate of mouse IgA immune complexes prepared with monomelic and dimeric IgA. J. Immunol. 1983; 130: 1826
   PubMedGoogle Scholar
• Brown T. A., Russel M. W., Mestecky J. Hepatobiliary transport of IgA immune complexes: molecular and cellular aspects. J. Immunol. 1982; 128: 2183
   PubMed Web of Science ®Google Scholar
• Peppard J., Orlans E., Payne A. W. R., Andrew E. The elimination of complement complexes containing polymeric IgA by excretion in bile. Immunology 1981; 42: 83
   PubMed Web of Science ®Google Scholar
• Harmatz P. R., Kleinman R. E., Bunnell B. W., Bloch K. J., Walker W. A. Hepatobiliary clearance of IgA immune complexes formed in the circulation. Hepatology 1982; 2: 328
   PubMedGoogle Scholar
• Vedeler C. A., Matre R. Complement receptor CR1 on human peripheral nerve fibers. J. Newoimmunol. 1988; 17: 315
   PubMedGoogle Scholar
• Thyresson H. N., McDuffie F. C., Schroeter A. L. C3b receptor in normal human skin. J. Invest. Dermatol. 1981; 77: 353
   PubMedGoogle Scholar
• Sorvillo J., Gigli L., Pearlstein E. Fibronectin binds to Clq associated antigen-antibody complexes in EDTA-treated plasma. Scand. J. Immunol. 1986; 23: 153
   PubMed Web of Science ®Google Scholar
• Carsons S. E., Schwartzman S., Diamond H. S., Berkowitz E. Interaction between fibronectin and Clq in rheumatoid synovial fluid and normal plasma. Clin. Exp. Immunol. 1988; 72: 37
   PubMedGoogle Scholar
• Gupta R. C., Simpson W. A., Raghow R. Interaction of fibronectin with DNA/anti-DNA complexes from systemic lupus erythematosus: role of activated complement CI in modulation of the interactions. Clin. Immunol. Immunopathol. 1988; 46: 368
   PubMedGoogle Scholar
• Zhang S. C., Schultz D. R., Ryan U. S. Receptor-mediated binding of Clq on pulmonary endothelial cells. Tissue Cell 1986; 18: 13
   PubMedGoogle Scholar
• Klaus G. G. B., Humphrey J. H., Kunkl A., Dongworth D. W. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 1980; 53: 3
   PubMedGoogle Scholar
• Stingl G., Tamaki K., Katz S. I. Origin and function of epidermal Langerhans cells. Immunol. Rev. 1980; 53: 149
   PubMed Web of Science ®Google Scholar
• Tew J. G., Phipps R. P., Mandel T. E. The maintenance and regulation of the humoral response: persisiting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol. Rev. 1980; 53: 203
   PubMedGoogle Scholar
• Beneveniste J., Mencia-Huesta J. M., Camussi G. Immune mechanism of immune complex deposition. Adv. Inflam. Res. 1979; 1: 353
   Google Scholar
• Ward P. A. Immune complex injury of the lung. Amer. J. Pathol. 1979; 97: 85
   PubMed Web of Science ®Google Scholar
• Emancipator S. N., Lamm M. E. Pathway of tissue injury initiated by humoral immune mechanisms. Lab. Invest. 1986; 54: 475
   PubMedGoogle Scholar
• Wilson C. B., Blantz R. C. Nephroimmunopathology and pathophysiology. Amer. Physiol. Soc 1985; 248: 319
   Google Scholar
• Herbert L. A., Cosio F. G. The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int. 1987; 31: 877
   PubMedGoogle Scholar
• Crothers D. M., Matzger H. The influence of poly-valency on the binding properties of antibodies. lmmunochemistry 1972; 9: 341
   PubMedGoogle Scholar
• Papalian M., Lafer E., Wong R., et al. Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1200 base pairs. J. Clin Invest. 1980; 65: 469
   PubMed Web of Science ®Google Scholar
• Van der Zee J. S., Van Swieter P., Aalberse R. C. Serological aspects of IgG4 antibodies. II. IgG4 antibodies form small non-precipitating immune complexes due to functional monovalency. J. Immunol 1986; 137: 3566
   PubMed Web of Science ®Google Scholar
• Phillips T. M., Queen W. D., Lewis M. G. The significance of circulating immune complexes in patients with malignant melanoma. Melanoma Antigens and Antibodies, R. A. Reisfeld, S. Ferrone. Academic Press, New York 1982; chap. 16
   Google Scholar
• Chen P. P., Fong S., Carson D. A. Rheumatoid factor. Rheum. Dis. Clinics N. Amer. 1987; 13: 545
   PubMed Web of Science ®Google Scholar
• Frank M. M. New developments in immunopathology with special reference to complement and immune complexes. Int. Arch. Allergy Appl. Immunol. 1985; 77: 89
   PubMedGoogle Scholar
• Germain M. J., Anderson R. W., Kaene W. F. Renal disease in cryoglobulinemia type II: response to therapy. A case report and review of the literature. Amer. J. Nephrol. 1982; 2: 221
   PubMedGoogle Scholar
• Winfield J. B., Koffler D., Kunkle H. G. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. J. Clin. Invest. 1975; 56: 563
   PubMed Web of Science ®Google Scholar
• Ng Y. C., Schiflerli J. A. Clearance of cryoglobulins in man. Springer Semin. Immunopathol. 1988; 10: 75
   PubMedGoogle Scholar
• Creighton W. D., Lambert P. H., Miescher P. A. Detection of antibodies and soluble antigen-antibody complexes by precipitation and polyethylene glycol. J. Immunol. 1973; 111: 1219
   PubMed Web of Science ®Google Scholar
• Siersted H. C., Brandslund I., Svehag S. E., Jensenius J. C. Quantisation of circulating immune complexes by combined PEG precipitation and immunoglobulin specific radioimmunoassay (PICRIA). Methods Enzymol. 1981; 74: 538
   PubMedGoogle Scholar
• Brandslund I., Siersted H. C., Jensenius J. C., Svehag S. E. Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods EnzymoL. 1981; 74: 551
   PubMedGoogle Scholar
• Virella G., Kilpatrick J. M., Chenais F., Fudenberg H. H. Isolation of soluble immune complexes from human serum: combined use of polyethylene glycol precipitation, gel filtration and affinity chromatography on protein A-sepharose. Methods Enzymol 1981; 74: 644
   PubMedGoogle Scholar
• Beneveniste J., Bruneau C. Detection and characterization of circulating immune complexes by ultracentrifugation: technical aspects. J. Immunol. Methods 1979; 26: 99
   PubMedGoogle Scholar
• Stanworth D. R., Johns P. Ultracentrifugal methods of detecting soluble immune complexes. Ann. Rheum. Dis. Suppl 1977; 36: 12
   Google Scholar
• Bruneau C., Benveniste J. Circulating DNA: anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation. J. Clin. Invest. 1979; 64: 191
   PubMedGoogle Scholar
• Rodahl E., Iversen O.-J., Dalen A. B. Preparative isolation of immune complexes from serum by sucrose density ultracentrifugation. Scand. J. Immunol. 1984; 20: 21
   PubMedGoogle Scholar
• Kauffman R. H., Van Es L. A., Daha M. R. Specific detection of IgA immune complexes. J. Immunol. Methods 1981; 40: 117
   PubMedGoogle Scholar
• Male D., Roitt I. M. Analysis of the components of immune complexes. Mol. Immunol. 1979; 16: 197
   PubMedGoogle Scholar
• Steensgard J., Jabobsen C. A new gradient former and simplified procedure for zonal centrifugation of immune complexes. J. Immunol. Methods 1979; 29: 173
   PubMedGoogle Scholar
• Melsom R. D., Horsfall A. C., Schrieber L., Charles P., Maini R. N. Anti-Clq affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease. Rheumatol. Int. 1986; 6: 227
   PubMedGoogle Scholar
• Pollard K. M., Webb J. Partial purification of anti-DNA antibodies from systemic lupus erythematosus serum by dye-ligand chromatography. J. Immunol. Methods 1982; 54: 81
   PubMedGoogle Scholar
• Hoffken K., Schmidt C. G. Quantification of immune complexes by nephelometry. Methods EnzymoL 1981; 74: 628
   PubMedGoogle Scholar
• Hack C. E., Belmer A. J. The IgG detected in the Clq solid-phase immune-complex assay is not always of immune complex nature. Clin. Immunol. Immunopathol. 1986; 38: 120
   PubMedGoogle Scholar
• Fukuda K., Seino J., Kinoshita Y., Sudo K., Horigome I., Saito T., Furuyama T., Yoshinaga K. Circulating immune complex-like materials which bind to heat inactivated Clq interfere with the Clq solid phase assay for immune complexes. Tohoku J. Exp. Med. 1985; 146: 449
   PubMedGoogle Scholar
• Agnello V., Winchester R. J., Kunkel H. G. Precipitin reactions of the Clq component of complement with aggregated IgG and immune complexes in gel diffusion. Immunology 1970; 19: 909
   PubMed Web of Science ®Google Scholar
• Zubler R. H., Carpentier N., Lambert P. H. The [125I] C1q binding assay for the detection of soluble immune complexes. Methods EnzymoL 1981; 74: 530
   PubMedGoogle Scholar
• Sobel A. T., Bokisch V. A., Muller-Eberhard H. J. C1q deviation test for the detection of immune complexes, aggregates of IgG and bacterial products in human sera. J. Exp. Med. 1975; 142: 139
   PubMed Web of Science ®Google Scholar
• Levinson S. S., Goldman J. O. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q binding and Raji cell methods. J. Clin. Microbiol. 1987; 25: 1557
   PubMedGoogle Scholar
• Theofilopoulos A. N. The Raji, conglutin, and anti-C3 assays for the detection of complement-fixing immune complexes. Methods Enzymol. 1981; 74: 511
   PubMedGoogle Scholar
• Eisenberg R. A., Theofilopoulos A. N., Dixon F. J. Use of bovine conglutinin for the assay of immune complexes. J. Immunol. 1977; 118: 1428
   PubMed Web of Science ®Google Scholar
• Durand C. G., Burge J. J. A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement, Findings in systemic lupus erythematosus. J. Immunol. Methods 1984; 73: 57
   PubMed Web of Science ®Google Scholar
• Naish P., Barratt J., Sindrey M. Assay of soluble immune complexes using radiolabeled rheumatoid factor. Methods Enzymol. 1981; 74: 617
   PubMedGoogle Scholar
• Gilead Z., Gazitt Y., Klein G., Sulitzeanu D. Purification and analysis of immune complexes with the aid of rheumatoid factor-coated tubes. Methods Enzymol. 1981; 74: 664
   PubMedGoogle Scholar
• Asbakk K., Iversen O. J. Rheumatoid factors in psoriatic lesions, serum and circulating immune complexes detected by an isotype-specific ELISA. Acta. Pathol. Microbiol. Immunol. Scand. 1987; 95(C)161
   Google Scholar
• Theofilopoulos A. N., Wilson C. B., Dixon F. J. The Raji cell radioimmune assay for detecting immune complexes in human sera. J. Clin. Invest. 1976; 57: 169
   PubMed Web of Science ®Google Scholar
• Horsfall A. C., Venables P. J. W., Mumford P. A., Maini R. N. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes. Clin. Exp. Immunol. 1981; 44: 405
   PubMedGoogle Scholar
• Salinas F. A., Wee K. H., Silver H. K. B. Immune complexes and human neoplasia: detection and quantitation of circulating immune complexes by the fetal liver cell assay. Cancer Immunol, lmmunother. 1981; 12: 11
   Google Scholar
• Salinas F. A., Wee K. H., Silver H. K. Clinical relevance of immune complexes, associated antigen and antibody in cancer. Contemp. Topics lmmunobiol. 1985; 15: 55
   PubMedGoogle Scholar
• Poskitt T. R., Poskitt P. K. F. The L1210 radioimmune assay for detecting circulating immune complexes. Immunol. Commun. 1978; 7: 543
   PubMed Web of Science ®Google Scholar
• Kammer G. M., Schur P. H. Binding of circulating immune complexes to human peripheral blood lymphocytes: effect of complement. Clin. Immunol. Immunopathol. 1978; 10: 202
   PubMedGoogle Scholar
• Myllyla G. Aggregation of human blood platelets by immune complexes in the sedimentation pattern test. Scand. J. Hematol. Suppl. 1973; 19: 1
   PubMedGoogle Scholar
• Palosuo T., Kano K., Anthone S., Gerbasi J. R., Milgrom F. Circulating immune complexes after kidney transplantation. Transplantation 1976; 21: 312
   PubMedGoogle Scholar
• Tsuda F., Miyakawa Y., Mayumi M. Application of human erythrocytes to a radioimmune assay of immune complexes in serum. Immunology 1979; 37: 681
   PubMedGoogle Scholar
• Morito T., Tanimoto K., Hashimoto Y., Horiuchi Y., Juji T. Fc-inhibition by hypocomplementaemic systemic lupus erythematosus sera. Ann. Rheum. Dis. 1976; 35: 415
   Google Scholar
• Barkas T., Al-Khateeb S. F., Irvine W. J., Davidson N. McD., Roscoe P. Inhibition of antibodydependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma. Clin. Exp. Immunol. 1976; 25: 270
   PubMed Web of Science ®Google Scholar
• Lightfoote M., Folkes T. M., Redfield R., Gold J., Marti G. E., Kelly J., Sell K. W. Flowcytometric detection of circulating immune complexes. J. Immunol. Methods 1986; 95: 107
   PubMedGoogle Scholar
• McHugh T. M., Stites D. P., Casavant C. H., Fulwyler M. J. Flow cytometric detection and quantitation of immune complexes using human C1q-coated microspheres. J. Immunol. Methods 1986; 95: 57
   PubMedGoogle Scholar
• Halgrem K., Wide L. Detection of IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann. Rheum. Dis. 1976; 35: 306
   PubMedGoogle Scholar
• Glikman G., Svehag S. E. Detection and quantitiation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA). Methods Enzymol. 1981; 74: 571
   PubMedGoogle Scholar
• Gupta R. K., Morton D. L. Clinical significance and nature of circulating immune complexes in melanoma patients. Contemp. Topics lmmunobiol. 1985; 15: 1
   PubMedGoogle Scholar
• Theofilopoulos A. N., Eisenberg R. A., Dixon F. J. Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum. J. Clin. Invest. 1978; 61: 1570
   PubMedGoogle Scholar
• Hogben D. N., Brown S. E., Howard C. R., Steward M. W. HBsAg: ami HBs immune complexes. A method for separating the constituent components and assessment of the affinity of the antibody. J. Immunol. Methods 1986; 93: 29
   PubMedGoogle Scholar
• Kazatchkine M., Mowbray J. F., Burton E. J., Sultan Y. Circulating immune complexes in hemophilia. Clin. Res. 1978; 26: 350A
   Google Scholar
• Davis J. S., Godfrey S. M., Winfield J. B. Direct evidence for circulating DNA-anti-DNA complexes in systemic lupus erythematosus. Arth. Rheum. 1978; 21: 17
   PubMedGoogle Scholar
• Rodahl E., Iversen O. J. Analysis of circulating immune complexes from patients with ankylosing spondylitis by gel electrophoresis and immunoblotting using antiserum against a psoriasis associated retrovirus-like particle. Ann. Rheum. Dis. 1986; 45: 892
   PubMedGoogle Scholar
• Morrow W. J.W., Wharton M., Strieker R. B., Levy J. A. Circulating immune complexes in patients with acquired immunodeficiency syndrome contain AIDS associated retrovirus. Clin. Immunol. Immunopathol. 1986; 40: 515
   PubMedGoogle Scholar
• Maidment B. W., Pepsidero L. D., Nemoto T., Chu T. M. Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing. Cancer Res. 1981; 41: 795
   PubMedGoogle Scholar
• Inman R. D., Rosenberg R. A., Redecha P. B., Christian C. L. Characterization of sequential immune complexes in infective endocarditis by Western blot analysis. J. Immunol. 1984; 133: 217
   PubMedGoogle Scholar
• Jorizzo J. L., McNeely M. C., Baughn R. E., Solomon A. R., Cavallo T., Smith E. B. Role of circulating immune complexes in human secondary syphilis. J. Infect. Dis. 1986; 153: 1014
   PubMedGoogle Scholar
• Kus J., Bergin C., Miller R., Ongley R., Churg A., Enarson D. Lymphocyte subpopulations in allergic granulomatosis and angiitis (Churg-Strauss syndrome). Chest 1985; 87: 826
   PubMedGoogle Scholar
• Carini C. IgE immune complexes in food allergies: significance, pathogenesis and clinical considerations. Clin. Allergy 1987; 17: 485
   PubMedGoogle Scholar
• Paganelli R., Quinti I., Carbonari M., Pontesilli O., D'Offlzi G. P., Lette T., Aiuti F. IgG anti-IgE in circulating immune complexes in the hyper-IgE syndrome. Clin. Allergy 1986; 16: 513
   PubMedGoogle Scholar
• Devey M. E., Bleasdale K. Antigen feeding modifies the course of antigen-induced immune complex disease. Clin. Exp. Immunol. 1986; 56: 637
   Google Scholar
• Paganelli R., Matricardi P. M., Aiuti F. Interactions of food antigens, antibodies and antigen-antibody complexes in health and disease. Clin. Rev. Allergy 1984; 2: 69
   PubMedGoogle Scholar
• Cunningham-Rundles C., Brandeis W. E., Good R. A., Day N. K. Milk precipitins, circulating immune complexes and IgA deficiency. Proc. Natl. Acad. Sci. (USA) 1978; 75: 3387
   PubMed Web of Science ®Google Scholar
• Coppo R., Basolo B., Rollino C., Roccatello D., Martina G., Amore A., Piccola G. Dietary gluten and primary IgA nephropathy. N. Engl. J. Med. 1986; 315: 1167
   PubMedGoogle Scholar
• Stevens W., Bridts C. H. IgG-containing and IgE-containing circulating immune complexes in patients with asthma and rhinitis. J. Allergy Clin. Immunol. 1984; 73: 276
   PubMedGoogle Scholar
• Lesourd B. M., Winters W. O., Kniker W. T. Changes in non-specific immune responses induced by repeated delayed-type hypersensitivity skin testing with multiple antigens. J. Clin. Lab. Immunol 1986; 19: 187
   PubMedGoogle Scholar
• Valentijn R. M., Van Overhagan H., Hazevoet H. M., Hermans J., Cats A., Daha M. R., Van Es L. A. The value of complement and immune complexe determination in monitoring disease activity in patients with systemic lupus erythematosus. Arth. Rheum. 1985; 28: 904
   PubMed Web of Science ®Google Scholar
• Frank M. M., Hamburger M. I., Lawley T. J., Kimberley R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N. Engl. J. Med. 1979; 300: 518
   PubMed Web of Science ®Google Scholar
• Parris T. M., Kimberley R. P., Inman R. D., McDougal J. S., Gibofsky M. D., Christian C. L. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nepritis. Ann. Int. Med. 1982; 97: 526
   PubMedGoogle Scholar
• Walport M. J., Lachman P. J. Erythrocyte complement receptor type 1, immune complexes and the rheumatic diseases. Arth. Rheum. 1988; 31: 153
   PubMed Web of Science ®Google Scholar
• Hass H., Havel A., Lange A., Gross W., Flad H. D., Schlaak M. Circulating immune complexes and NK activity in systemic lupus erythematosus. Immunol. Infekt. 1984; 12: 109
   PubMedGoogle Scholar
• Wager O., Lindstrom P., Rasanen J. A., Kekomaki R., Ziola B., Salmi A., Isomaki H., Skrifvars B., Penttinen K. Evaluation of 6 tests for circulating IgG complexes with special reference to IgM rheumatoid factors. Multivariate statistical analysis of clinically characterized systemic lupus erythematosus and rheumatoid arthritis series. Clin. Exp. Immunol. 1981; 45: 149
   Google Scholar
• Lambert P. H., Dixon F. J., Zubler R. H., Agnello V., Cambiaso C., Casali P., Clarke J., Cowdrey J. S., McDuffie F. C., Hay F. C., MacLennan I. C. M., Masson P., Muller-Eberhard H. J., Penttinen K., Smith M., Tappeiner G., Theofilopoulos A. N., Verroust P. WHO collaborative study for the evaluation of eighteen methods for detecting immune complexes in serum. J. Clin. Lab. Immunol. 1978; 1: 1
   Google Scholar
• Jones J. V., Robinson M. F., Parciany R. K., Layfer L. F., McLeod B. Therapeutic plasmapheresis in systemic lupus erythematosus. Arth. Rheum. 1981; 24: 1113
   PubMedGoogle Scholar
• Boyd R. E., Birchmore D. A., Kaiser D. L., Young A. C., Davis J. S. Acute effect of steroids on immune complex profile of patients wjth systemic lupus erythematosus. Correlation of profile with development of target organ involvement. Arth. Rheum. 1983; 26: 837
   Google Scholar
• Mitchell J. A., Batchelor J. R., Chapel H., Spiers C. N., Sim E. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complexes (CIC) levels in hydrazine-induced SLE. Clin. Exp. Immunol. 1987; 68: 446
   PubMed Web of Science ®Google Scholar
• Lin R. Y., Racis S. P. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration. Int. Arch. Allergy Appl. Immunol. 1986; 79: 286
   PubMedGoogle Scholar
• Deguchi Y., Hara H., Negoro S., Kakunaga T., Kishimoto S. Protooncogene expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus as an indicator of the disease activity. Clin. Immunol. Immunopathol. 1987; 45: 424
   PubMedGoogle Scholar
• Sheppeard H., Lee D. J., Ward D. J. Synovial fluid total hemolytic complement activity in rheumatic diseases - a reappraisal. J. Rheum. 1981; 8: 390
   PubMed Web of Science ®Google Scholar
• McDougal J. S., Hubbard M., McDuffie F. C., Strobel P. L., Smith S. J., Bass N., Goldman J. A., Hartman S., Myerson G., Miller S., Morales R., Wilson C. H. Comparison of five assays for immune complexes in the rheumatic diseases. Arth. Rheum. 1982; 25: 1156
   PubMedGoogle Scholar
• Gioud-Paquet M., Auvinet M., RafTin T., Girard P., Bouvier M., Lejeune E., Monier J. C. IgM rheumatoid factor (RF), IgA RF, IgE RF and IgG RF detected by ELISA in rheumatoid arthritis. Ann. Rheum. Dis. 1987; 46: 65
   PubMed Web of Science ®Google Scholar
• Melsom R. D., Smith P. R., Maini R. N. Demonstration of an unidentified 48 kD polypeptide in circulating immune complexes in rheumatoid arthritis. Ann. Rheum. Dis. 1987; 46: 104
   PubMedGoogle Scholar
• Singh V. K., Tingle A. J., Schulzer M. Rubella-associated arthritis. II. Relationship between circulating immune complex levels and joint manifestations. Ann. Rheum. Dis. 1986; 45: 115
   PubMedGoogle Scholar
• Forster P. J., McConkey B. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis. Quart. J. Med. 1986; 58: 29
   PubMedGoogle Scholar
• Westedt M. L., Vermeer B. J., Meijar C. J., Daha M. R., Baldwin W. M., Cats A. Immunopathological abnormalities in the normal skin of patients with rheumatoid arthritis in relation to clinical and serological findings: a one year follow up study. Ann. Rheum. Dis. 1987; 46: 213
   PubMedGoogle Scholar
• Sugisaki T., Ito S., Shibata T. The nature of immune complexes in glomeruli and anti-nuclei antibodies cross-reactivity with human IgG Fc fragments in mixed connective tissue disease patients. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies, R. Kasukawa, G. C. Sharp. Elsevier Scientific Publications, Amsterdam 1987; 127
   Google Scholar
• Bennett R. M., Spargo B. H. Immune complexes in mixed connective tissue disease. Amer. J. Med. 1977; 63: 534
   PubMed Web of Science ®Google Scholar
• Thompsen B. S., Oxholm P., Manthorpe R., Nielson H. Complement C3b receptors on erythrocytes, circulating immune complexes and complement C3 split products in patients with primary Sjogren's syndrome. Arth. Rheum. 1986; 29: 857
   PubMedGoogle Scholar
• Lawley T. J., Moutsopoulos H. M., Katz S. I., Theofilopoulos A. N., Chused T. M., Frank M. M. Demonstration of circulating immune complexes in Sjogren's syndrome. J. Immunol. 1979; 123: 1382
   PubMed Web of Science ®Google Scholar
• Fischbach M., Char D., Christensen M., Daniels T., Whaley K., Aspaugh M., Talal N. Immune complexes in Sjogren's syndrome. Arth. Rheum. 1980; 23: 791
   PubMedGoogle Scholar
• Yoshinoya S., McDuffy S., Alarcon-Segovia D., Pope R. M. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis and Sjogren's syndrome and wiui Sjogren's syndrome alone. Clin. Exp. Immunol. 1982; 48: 339
   PubMedGoogle Scholar
• Bruneau C., Bonin H. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis. Clin. Exp. Immunol. 1983; 53: 529
   PubMedGoogle Scholar
• Rodahl E., Asbakk K., Iversen O.-J. Participation of antigens related to the psoriasis associated antigen, pso p27, in immune complex formation in patients with ankylosing spondylitis. Ann. Rheum. Dis. 1988; 47: 628
   PubMed Web of Science ®Google Scholar
• Peeters A. J., van den Wall Bake A. W. L., Van Dalsen A. D., Westedt M. L. Relation of microscopic haematuria in ankylosing sponylitis to circulating IgA containing immune complexes. Ann. Rheum. Dis. 1988; 47: 645
   PubMedGoogle Scholar
• Seibold J. R., Medsger T. A., Winkelstein A., Kelly R. H., Rodnan G. P. Immune complexes in progressive sclerosis (scleroderma). Arth. Rheum. 1982; 25: 1167
   PubMedGoogle Scholar
• Meretey K., Falus A., Bohn U., Permin H., Wiik A. IgE class immune complexes in Felty's syndrome. Characterization of antibody activities in isolated complexes. Ann. Rheum. Dis. 1985; 63: 246
   Google Scholar
• Lindgren S., Laurell A. B., Eriksson S. Complement components and activation in primary biliary cirrhosis. Hepatology 1984; 4: 9
   PubMed Web of Science ®Google Scholar
• Okabe N., Fujita K., Takenaka K., Yao T. Immunological studies on Crohn's disease. IV. Decreased ADCC activity. J. Clin. Lab. Immunol. 1986; 19: 77
   PubMedGoogle Scholar
• Furuse A., Matsuda I. Circulating immune complexes in the mucocutaneous lymph node syndrome. Eur. J. Pediatr. 1983; 141: 50
   PubMedGoogle Scholar
• Nussenblatt R. B., Palestine A. G., Chan C. C., Mochizuki M., Yancey K. Effectiveness of cyclosporin therapy for Behçet's disease. Arth. Rheum. 1985; 28: 671
   PubMed Web of Science ®Google Scholar
• Carpentier N. A., Miescher P. A. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavourable prognosis. J. Clin. Invest. 1977; 60: 874
   PubMed Web of Science ®Google Scholar
• Chollet P., Carpentier N., Chassagne G., Betail J. M., Bidet P. H., Lambert P. H., Plagne R. Clinical relevance of circulating immune complexes in breast cancer. Int. Symp. New Trends Human Immunol, and Cancer Immunotharapy, B. Serrou, C. Rosenfeld. Dion/Saunders, Paris 1980; 496
   Google Scholar
• Hubbard R. A., Aggio M. C., Lozzio B. B., Wust D. J. Correlation of circulating immune complexes and disease status in patients with leukemia. Clin. Exp. Immunol. 1981; 121: 2485
   Google Scholar
• Minden P., Odom L. M., Tubergen D. G., Hardtke M. A., Sbarpton T. R., Rose B., Zlotnick A., Carr R. I. Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy. Cancer 1980; 45: 460
   PubMedGoogle Scholar
• Pesce A. J., Phillips T. M., Ooi B. S., Evans A., Shank R. A., Lewis M. G. Immune complexes in transitional cell carcinoma. J. Urol. 1980; 123: 486
   PubMedGoogle Scholar
• Williams R. C., Duncan M. H., Tung K. S. K., Stinton E. R., Walker L. C., Greaves M. F. Characterization of immune complexes in acute lymphoblastic leukemia. Clin. Exp. Immunol. 1983; 54: 418
   PubMedGoogle Scholar
• Bharwani N., Campbell L., Ashley P., Queen W. D., Phillips T. M., Jerry L. M. Circulating immune complexes in malignant melanoma: serial studies in 130 patients. Oncology 1986; 43: 143
   PubMedGoogle Scholar
• Mukhopadhyaya R., Rao R. S., Fakih A. R., Gangal S. G. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity. J. Clin. Lab. Immunol 1986; 21: 189
   PubMedGoogle Scholar
• Wong J. M., Gupta R. K., Morton D. L. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma. Arch. Surg. 1986; 121: 1342
   PubMed Web of Science ®Google Scholar
• Fekete B., Fust G., Pal A., Angyal I., Jakab A., Meratay K., Falus A., Torok K., Szeged G., Kavai M., Puskas E., Csecal-Nagy M., Szabo T., Lenkey A., Misz M. Clinical correlates of circulating immune complex levels in advanced lung cancer. A discrimination analysis. Oncology 1983; 40: 106
   PubMed Web of Science ®Google Scholar
• Chao K. C., Liu C. C., Ng H. T., Hu C. P., Chang C. M. Circulating immune complexes in cervical cancer patients as detected by Clq binding. Proc. Natl. Sci. Council. Rep. China 1984; 8: 50
   PubMedGoogle Scholar
• Das S. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients. Arch. Geschwulstforsch 1987; 57: 283
   PubMedGoogle Scholar
• Mavligit G. M., Stuckey S. Colorectal carcinoma. Evidence for circulating CEA-anti-CEA complexes. Cancer 1983; 52: 146
   PubMed Web of Science ®Google Scholar
• Steele G., Lahey S., Rodrick M., Ross D., Deasey J., Zamcheck N., Osteen R., Wilson R. Circulating immune complexes in patients with colorectal cancer. Amer. J. Surg. 1983; 145: 549
   PubMed Web of Science ®Google Scholar
• Shafir M., Martinelli G., Bekesi J. G., Jaramillo S., Heimann T., Aufses A. H. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD). Eur. J. Surg. Oncol. 1986; 12: 351
   PubMedGoogle Scholar
• Koldovsky P., Koldovsky U., Ebbers J., Vosteen K. H. Stimulation of peripheral blood lyphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinoma. Arch. Otorhinolaryngol 1986; 243: 309
   PubMedGoogle Scholar
• Horvath M., Fekete B., Rahoty P. Investigation of circulating immune complexes in patients with breast cancer. Oncology 1982; 39: 20
   PubMedGoogle Scholar
• Hooper D. C., Bayer A. S., Karchmer A. W., Theofilopoulos A. N., Swartz M. N. Circulating immune complexes in prosthetic valve endocarditis. Arch. Intern. Med. 1983; 143: 2081
   PubMedGoogle Scholar
• Coyle P. V., Thompson J., Adgey A. A., Rutter D. A., Fay A., McNeill T. A., Connolly J. H. Changes in circulating immune complex concentrations and antibody titres during treatment of Q fever endocarditis. J. Clin. Pathol 1985; 38: 743
   PubMedGoogle Scholar
• Kerr M. A., Wilton E., Naama J. K., Whaley K. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis. Clin. Exp. Immunol. 1986; 63: 359
   PubMedGoogle Scholar
• Gerli R., Ranbotti P., Spinozzi F., Bertotto A., Chiodini V., Solinas P., Gemini I., Davis S. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy. Amer. Heart J. 1986; 112: 350
   PubMedGoogle Scholar
• Schifferli J. A., Steiger G., Polla L., Didierjean L., Saurat J. H. Activation of the alternate pathway of complement by skin immune deposits. J. Invest. Dermatol. 1985; 85: 407
   PubMedGoogle Scholar
• Hall R. P., Lawley T. J., Heck J. A., Katz S. I. IgA-containing complexes in dermatitis herpetiformis, Henoch-Schonlein purpura, systemic lupus erythematosus and other diseases. Clin. Exp. Immunol. 1980; 40: 431
   PubMedGoogle Scholar
• Hall R. P., Eyre R. W. IgA immune complexes in patients with dermatitis herpetiformis occur in the absence of IgA rheumatoid factor. J. Invest. Dermatol. 1987; 89: 27
   PubMedGoogle Scholar
• Zone J. J., LaSalle B. A., Provast T. T. Induction of IgA circulating immune complexes after wheat feeding in dermatitis herpetiformis patients. J. Invest. Dermatol. 1982; 78: 375
   PubMed Web of Science ®Google Scholar
• Bushkill L. L., Markel S. E., Jordon R. E. Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J. Invest. Dermatol. 1980; 76: 372
   Google Scholar
• Tosca N., Stratigos J. D. Possible pathogenetic mechanisms in allergic cutaneous vasculitis. Int. J. Derm. 1988; 27: 291
   PubMedGoogle Scholar
• Kida H., Asamoto T., Abe T., Tomosugi N., Hattor N. Psoriasis vulgaris associated with mesangiocapillary glomerulonephritis. Clin. Nephrol. 1985; 23: 255
   PubMedGoogle Scholar
• Brohee D., Delepesse G., Debisschop M. J., Bonnyns M. Circulating immune complexes in various thyroid diseases. Clin. Exp. Immunol. 1978; 36: 379
   Google Scholar
• Burman K. D., Baker J. R. Immune mechanisms in Graves'. disease, Endocrinol. Rev. 1985; 6: 183
   PubMed Web of Science ®Google Scholar
• Horvath F., Teague P., Gaffney E. F., Mars D. R., Fuller T. J. Thyroid antigen associated immune complex glomerulonephritis in Graves' disease. Amer. J. Med. 1979; 67: 901
   PubMedGoogle Scholar
• Endo Y., Aratake Y., Yamamoto I., Nakaqawa H., Kuribayashi T., Ohtaki S. Peripheral K cells in Graves' disease and Hashimoto's thyroiditis in relation to circulating immune complexes. Clin. Endocrinol. 1983; 18: 187
   PubMedGoogle Scholar
• Irvine W. J., DiMario V., Guy K., Borsey D. Q. Immune complexes in Type I diabetes mellitus with and without persistent islet cell antibody. J. Clin. Lab. Immunol. 1980; 4: 87
   PubMedGoogle Scholar
• Hilgartner M. W., Inman K. D., Miller C. H. Increased circulating immune complex levels in hemophilia patients post-infusion. Thromb. Haemostasis 1981; 46: 189
   Google Scholar
• Kazatchkine M. D., Sultan Y., Burton-Kee E. J., Mowbray J. F. Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A. Clin. Exp. Immunol. 1980; 39: 315
   PubMedGoogle Scholar
• Lazarchick J., Hoyer L. W. The properties of immune complexes formed by human antibodies to factor VIII. J. Clin. Invest. 1977; 60: 1070
   PubMed Web of Science ®Google Scholar
• Clancy R., Trent R., Danis V., Davidson R. Autosensitization and immune complexes in chronic idiopathic thrombocytopenic purpura. Clin. Exp. Immunol. 1980; 39: 170
   PubMedGoogle Scholar
• van der Veen J. P., Goldschmeding R., Miedema F., Smit J. W., Melief C. J., von dem Borne A. E. K-cell lymphocytosis/neutropenia syndrome: the neutropenia is not caused by autoimmunity. Brit. J. Haematol 1986; 64: 777
   PubMed Web of Science ®Google Scholar
• Brown S. E., Steward M. W., Viola L., Howard C. R., Murray-Lyon I. M. Chronic liver disease: the detection and characterization of circulating immune complexes. Immunology 1983; 49: 673
   PubMed Web of Science ®Google Scholar
• Ray M. B., Desmet V. J., Bradburne A. F., Desmyter J., Fevery J., DeGroote J. Hepatitis B core antigen immune complexes in the liver of hepatatis B patients. Clin. Exp. Immunol. 1979; 37: 15
   PubMedGoogle Scholar
• Rath S., Devey M. E. IgG subclass composition of antibody to HBsAg in circulating immune complexes from patients with hepatitis B virus infection. Clin. Exp. Immunol. 1988; 72: 164
   PubMedGoogle Scholar
• Araki K., Nagashima H., Tsuji T. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis. Clin. Exp. Immunol. 1982; 47: 520
   PubMedGoogle Scholar
• Tiku M. L., Beutner K. R., Ogra P. L. Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers. Clin. Exp. Immunol. 1979; 36: 54
   PubMedGoogle Scholar
• Stagno S., Volanakis J. E., Reynolds D. W., Stroud R., Alford C. A. Immune complexes in congenital and natal cytomegalovirus infections in man. J. Clin. Invest. 1977; 60: 838
   PubMedGoogle Scholar
• Hirsch M. S., Felsenstein D. Cytomegalovirus-induced immunosuppression. Ann. NY. Acad. Sci. 1984; 437: 8
   PubMedGoogle Scholar
• Gupta S., Licorish K. Circulating immune complexes in AIDS. N. Engl. J. Med. 1984; 310: 1530
   PubMedGoogle Scholar
• Tausk F. A., McCutchan J. A., Spechko P., Schreiber R. D., Gigli I. Altered erythrocyte C3b receptor expression, immune complexes and complement activation in homosexuals in varying risk groups for acquired immuno-deficiency syndrome. J. Clin. Invest. 1986; 78: 977
   PubMed Web of Science ®Google Scholar
• Lightfoote M. M., Folks T. M., Redfield R., Gold J., Sell K. W. Circulating IgA immune complexes in AIDS. Immunol. Invest. 1985; 14: 341
   PubMed Web of Science ®Google Scholar
• Procaccia S., Lazzarin A., Colucci A., Gasparini A., Forcellini P., Lanzanova D., Foppe C. U., Novati R., Zanussi D. IgM, IgG, and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities. Clin. Exp. Immunol. 1987; 67: 236
   PubMedGoogle Scholar
• Morrow W. J. W., Wharton M., Strieker R. B., Levy J. A. Circulating immune complexes in patients with acquired immunodeficiency syndrome contain the AIDS-associated retrovirus. Clin. Immunol. Immunopath. 1986; 40: 515
   PubMedGoogle Scholar
• Carini C., Mezzaroma I., Scano G., D'Amelio R., Matricardi P., Aiuti F. Characterization of specific immune complexes in HTV-related disorders. Scand. J. Immunol. 1987; 26: 21
   PubMedGoogle Scholar
• Karpatkin S. Idiopathic thrombocytopenic purpura in homosexual men. Ann. N.Y. Acad. Sci. 1984; 437: 58
   PubMedGoogle Scholar
• Jackson S., Dawson L. M., Kotler D. P. IgA1 is the major immunoglobulin component of immune complexes in acquired immunodeficiency syndrome. J. Clin. Immunol. 1988; 8: 64
   PubMed Web of Science ®Google Scholar
• Ruangjirachuporn W., Boonpucknavig S., Nimmanitya S. Circulating immune complexes in serum from patients with dengue hemorrhagic fever. Clin. Exp. Immunol. 1979; 36: 46
   PubMed Web of Science ®Google Scholar
• Julkunen I., Brummer-Korvenkontio M., Hautanan A., Kuusisto P., Lindstrom P., Wager O., Penttinen K. Elevated serum immune complexes in Pogosta disease, an acute alphavirus infection with rash and arthritis. J. Clin. Lab. Immunol. 1986; 21: 77
   PubMedGoogle Scholar
• McNeely M. C., Jorizzo J. L., Solomon A. R., Smith E. B., Cavallo T., Sanchez R. L. Cutaneous secondary syphilis: preliminary immunohistopathologic support for a role for immune complexes in lesion pathogenesis. J. Amer. Acad. Dermatol. 1986; 14: 564
   PubMedGoogle Scholar
• Baughn R. E., McNeely M. C., Jorizzo J. L., Musher D. M. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis. J. Immunol. 1986; 136: 1406
   PubMedGoogle Scholar
• Manicourt D. H., Orloff S. Gonococcal arthritis - dermatitis syndrome: study of serum and synovial fluid immune complex levels. Arth. Rheum. 1982; 25: 574
   PubMedGoogle Scholar
• Friedman J., van de Rijn I., Ohkuni H., Fischetti V. A., Zabriskie J. B. Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. J. Clin. Invest. 1984; 74: 1027
   PubMed Web of Science ®Google Scholar
• Virendra N., Sehgal V. N., Srivastava G., Sundharam J. A. Immunology of reactivity in leprosy. Int. J. Derm. 1988; 27: 157
   PubMedGoogle Scholar
• Bonomo L., Dammacco F. Immune complex cryoglobulinemia in lepromatous leprosy: a pathogenetic approach to some clinical features of leprosy. Clin. Exp. Immunol. 1971; 9: 175
   PubMed Web of Science ®Google Scholar
• Bjorvatn B., Barnetson R. S., Kronvall G., Zubler R. H., Lambert P. H. Immune complexes and complement hyper-catabolism with leprosy. Clin. Exp. Immunol. 1976; 26: 388
   PubMed Web of Science ®Google Scholar
• Cologlu A. S. Immune complex glomerulonephritis in leprosy. Lepr. Rev. 1979; 50: 213
   PubMed Web of Science ®Google Scholar
• Ridley M. J., Ridley D. S. The immunopathology of erythema nodosum leprosum. The role of extravascular complexes. Lepr. Rev. 1983; 54: 95
   PubMedGoogle Scholar
• Ashtekar M. D., Dhalla A. S., Mazarello T. B. M. S., Samuel A. M. A study of Mycobacterium tuberculosis antigen and antibody in cerebrospinal fluid and blood in tuberculosis meningitis. Clin. Immunol. Immunopathol. 1987; 45: 29
   PubMedGoogle Scholar
• Ooi Y. M., Ooi B. S., Pollack V. E. Relationship of levels of circulating immune complexes in histologic patterns of nephritis: a comparative study of membraneous glomerulonephritis and diffuse proliferative glomerulonephritis. J. Lab. Clin. Med. 1977; 90: 891
   PubMed Web of Science ®Google Scholar
• Levinsky R. J., Cameron J. S., Soothill J. F. Serum immune complexes and disease activity in lupus nephritis. Lancet 1977; 1: 564
   PubMed Web of Science ®Google Scholar
• Czerkinsky C., Koopman W. J., Jackson S., Collins J. E., Crago S. S., Schrohenloher R. E., Julian B. A., Galla J. H., Mestecky J. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial A nephropathy. J. Clin. Invest. 1986; 77: 1931
   PubMed Web of Science ®Google Scholar
• Yagame M., Tomino Y., Miura M., Tanigaki T., Suga T., Nomoto Y., Sakai H. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA). Clin. Exp. Immunol. 1987; 67: 270
   PubMedGoogle Scholar
• Sancho J., Egido J., Sanchez-Crespo M., Blasco R. Detection of mono and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic kidney disease. Clin. Exp. Immunol. 1982; 47: 327
   PubMed Web of Science ®Google Scholar
• Coppo R., Basolo B., Martina G., De Rollino C, Marchi M., Giacchino F., Mazzucco G., Messina M., Piccoli G. Circulating immune complexes containing IgA, G, and M in patients with IgA nephropathy and with Henloch-Schonlein nephritis. Correlation with clinical and histological signs of activity. Clin. Nephrol. 1982; 18: 230
   PubMedGoogle Scholar
• Yap H. K., Sakai R. S., Woo K. T., Lim C. H., Jordan S. C. Detection of bovine serum albumin in the circulating immune complexes of patients with IgA nephropathy. Clin. Immunol. Immunopathol. 1987; 43: 395
   PubMedGoogle Scholar
• Nagy J., Scott H., Brandtzaeg P. Antibodies to dietary antigen in IgA nephropathy. Clin. Nephrol. 1988; 29: 255
   Google Scholar
• Waner M. H., Mannik M., Schwartz M. M., Lewis E. J. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) 1987; 66: 85
   PubMedGoogle Scholar
• Ooi Y. M., Ooi B. S., Pollak V. E. Relationship of levels of circulating immune complexes to histologic patterns of nephritis. A comparative study of membraneous glomerulonephropathy and diffuse proliferative glomerulonephritis. J. Lab. Clin. Med. 1977; 90: 891
   PubMed Web of Science ®Google Scholar
• Tina L. U., Phillips T. M., Calcagno P. L. Autoantibodies in minimal change nephrotic syndrome. Int. J. Pediatr. Nephrol. 1984; 5: 63
   PubMedGoogle Scholar
• Klein M. H., Thorner P. S., Yoon S.-J., Poucell S., Baumal R. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibodies in different classes of lupus nephritis. Int. J. Pediat. Nephrol. 1984; 5: 75
   PubMedGoogle Scholar
• Dosa S., Phillips T. M., Antonovych T. T., Segal A., Guha A., Thompson A. M. Acute myelomonocytic leukemia associated with nephrotic syndrome. Nephron. 1983; 34: 125
   PubMedGoogle Scholar
• Gilboa N., Durante D., Guggenheim S., Lacher J. Immune deposit nephritis and single component cryoglobulinemia associated with chronic lymphocytic leukemia. Evidence for a role of circulating IgG-anti-IgG immune complexes in the pathogenesis of the renal lesion. Nephron. 1979; 24: 223
   PubMedGoogle Scholar
• Hory B., Blanc D., Boillot A., Panouse-Perrin J. Guillain-Barre syndrome following danazol and corticosteroid therapy for heredity angioedema. Amer. J. Med. 1985; 79: 111
   PubMedGoogle Scholar
• Sanders M. E., Koski C. L., Robbins D., Shiu M. L., Frank M. M., Joiner K. A. Activated terminal complement in cerebral spinal fluid in Guillian Barre syndrome and multiple sclerosis. J. Immunol. 1986; 136: 4456
   PubMed Web of Science ®Google Scholar
• Phillips T. M., Manz H. J., Smith F. A., Jaffe H. A., Cohen S. L. The detection of anti-cholinesterase antibodies in myasthenia gravis. Ann. N.Y. Acad. Sci. 1981; 377: 360
   PubMed Web of Science ®Google Scholar
• Sharon G. E., Gawry I. M. S. Terminal complement complex (TCC) in isolated central nervous system vasculitis. J. Allerg. Clin. Immunol. 1987; 79: 177
   Google Scholar
• Tsukada N., Koh Ch. S., Yanagisawa N., Tsukagoshi H. Nervous tissue injury induced by immune complexes. Acta Neuropath. 1982; 56: 279
   PubMedGoogle Scholar
• Takeda M., Machida M., Nakano T., Tsukada N., Yang N. A case of vasculitic neuropathy with pulmonary tuberculosis, anti-endothelial cell activity and increased serum level of immune complexes. Clin. Neurol. 1986; 26: 727
   Google Scholar
• Salmi A., Zida B., Reunanen M., Julkunen I., Wager O. Immune complexes in serum and cerebral spinal fluid of multiple sclerosis patients and patients with other neurological disease. Acta Neurol. Scand. 1982; 66: 1
   PubMedGoogle Scholar
• Tanaka Y., Tsukada N., Koh Ch. S., Yanagisawa N. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis. J. Neuroimmunol. 1987; 17: 49
   PubMed Web of Science ®Google Scholar
• Schocket A. I., Carr R. I., Hardtke M. A. A comparison of 125I Clq binding, Raji cell binding and lymphocytotoxic activity in multiple sclerosis. Clin. Immunol. Immunopathol. 1980; 17: 477
   PubMedGoogle Scholar
• Wajgt A., Gorny M. K., Jenek R. The influence of high-dose prednisone medication on autoantibody specific activity and on circulating immune complex level in cerebrospinal fluid of multiple sclerosis patients. Acta Neurol. Scand. 1983; 68: 378
   PubMed Web of Science ®Google Scholar
• Salmi A., Lund G., Ziola B., Reunanen M. Circulating immune complexes in patients with subacute sclerosing panencephalitis. Clin. Immunol. Immunopathol. 1986; 41: 16
   PubMedGoogle Scholar
• Jackson W. B., Gilmore N. J. Ocular immunology: a review. Can. J. Ophlhamol. 1981; 16: 3
   PubMedGoogle Scholar
• Dernouchamps J. P., Michiels J. Circulating antigen-antibody complexes in the aqueous humor. Immunology and Immunopathology of the Eye, A. M. Silverstein, G. R. O'Connor. Masson Publishing, New York 1979; 40
   Google Scholar
• Char D. H., Stein P., Masi R., Christensen M. Immune complexes in Uveitis. Amer. J. Ophthalmol. 1979; 87: 678
   PubMed Web of Science ®Google Scholar
• Puglise J. V., Rao N. A., Weiss R. A., Phillips T. M., Marak G. E. Ocular features of Kawasaki's disease. Arch. Ophthalmol. 1982; 100: 1101
   PubMedGoogle Scholar
• Matsuo T., Date S., Tsuji T., Koyama M., Nakayama T., Koyama T., Matsuo N., Koide N. Immune complex containing herpes virus antigen in a patient with acute retinal necrosis. Amer. J. Ophthalmol. 1986; 101: 368
   PubMedGoogle Scholar
• Lambert P. H., Goldman M., Rose L. M. Immune complexes, polyclonal B-cell activation and idiotypic interactions in protozoan diseases. Fortschr. Zool. 1982; 27: 117
   Google Scholar
• Lambert P. H., Berney M., Kazyumba G. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlations with polyclonal B-cell activation and with intracerebral immunoglobulin synthesis. J. Clin. Invest. 1981; 67: 77
   PubMed Web of Science ®Google Scholar
• Goldman M., Rose L. M., Hochmann A., Lambert P. H. Renal deposition of idiotype-anti-idiotype complexes in renal glomerulus after polyclonal B cell activation. J. Exp. Med. 1982; 155: 1385
   PubMedGoogle Scholar
• Siegal J. P., Remington J. S. Circulating immune complexes in toxoplasmosis: detection and clinical correlations. Clin. Exp. Immunol. 1983; 52: 157
   PubMedGoogle Scholar
• Galvao-Castro B., Sa-Ferreira J. A., Marzochi K. F., Marzochi M. C., Coutinho S. G., Lambert P. H. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin. Exp. Immunol. 1984; 56: 58
   PubMed Web of Science ®Google Scholar
• Lawley T. J., Ottesen E. A., Hiatt R. A., Gazze L. A. Circulating immune complexes in acute schistosomiasis. Clin. Exp. Immunol. 1979; 37: 221
   PubMed Web of Science ®Google Scholar
• Stevens W. J., Feldman H., Bridts C. H., Daffalla A. A. IgG and IgE circulating immune complexes, total serum IgE and parasite related IgE in patients with mono- or mixed infection with Schistosoma mansoni and/or S. haematobium Influence of therapy. Clin. Exp. Immunol. 1983; 52: 142
   Google Scholar
• Feldmeier H., Stevens W. J., Bridts C. H., Daffalla A. A., Buttner D. W. Effect of chemotherapy and reinfection on IgE-containing and IgG-containing circulating immune complexes, serum IgE and IgE antibodies in patients chronically infected with Schistosoma mansoni and Schistosoma haematobium. Int. Arch. Allergy Appl. Immunol. 1983; 72: 211
   PubMedGoogle Scholar
• Butterworth A. E., Remold H. G., Houba V., David J. R., David F., David P., Sturrock R. F. Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomulae of Schistosoma mansoni: mediation by IgG and inhibition by antigen-antibody complexes. J. Immunol. 1977; 118: 2230
   PubMedGoogle Scholar
• Kamal K. A., Higashi G. I. Suppression of mitogen-induced lymphocyte transformation by plasma from patients with hepatosplenic Schistosomiasis mansonii: role of immune complexes. Parasite Immunol. 1982; 4: 283
   PubMedGoogle Scholar
• Greenfield D. I., Hughes W. S., Phillips T. M., Barth W. F. Immune complex arthritis in a patient with Schistosoma mansoni infection. Arth. Rheum. 1986; 29: 296
   PubMedGoogle Scholar
• Steward M. W., Sisley B., Mackenzie C. D., El Sheikh H. Circulating immune complexes in onchocerciasis. Clin. Exp. Immunol. 1982; 48: 17
   PubMed Web of Science ®Google Scholar
• Vinayak V. K., Purnima V., Singh K., Venkatwswaslu K., Nairn C. K., Mahte S. K. Specific circulating immune complexes in amoebic liver abcess. J. Clin. Microbiol. 1986; 23: 1088
   PubMedGoogle Scholar
• Silver R. M., Metcalf J. F., LeRoy E. C. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. Arth. Rheum. 1986; 29: 525
   PubMedGoogle Scholar
• Gelb A. F., Dreisin R. B., Epstein J. D., Silverthorne J. D., Bickel Y., Fields M., Border W. A., Taylor C. R. Immune complexes, gallium scans and bronchoalveolar lavage in idiopathic interstitial pneumonitis: a structure-function clinical study. Chest 1983; 84: 148
   PubMed Web of Science ®Google Scholar
• Haslam P. L., Thompson B., Mohammed I., Townsend P. J., Hodson M. E., Marlborow E. J., Turner-Warwick M. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin. Exp. Immunol. 1979; 37: 381
   PubMed Web of Science ®Google Scholar
• Dreisin R. B., Schwartz M. I., Theofilopoulos A. N., Stanford R. E. Circulating immune complexes in the idiopathic interstitial pneumonias. N. Engl. J. Med. 1978; 298: 353
   PubMed Web of Science ®Google Scholar
• Crystal R. G., Gadek J. E., Ferrans V. J., Fulmer J. D., Line B. R., Hunninghake G. W. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Amer. J. Med. 1981; 70: 542
   PubMed Web of Science ®Google Scholar
• Das Gupta M. K., Lam J., Doring G., Harley F. L., Zuberbuhier P., Lam K., Reichert A., Costerton J. W., Dossetor J. B. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis. J. Clin. Lab. Immunol. 1987; 23: 25
   PubMedGoogle Scholar
• Disis M. L., McDonald T. L., Colombo J. L., Kobayashi R. H., Angle C. R., Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr. Res. 1986; 20: 385
   PubMedGoogle Scholar
• Moss R. B., Hsu Y.-P. Isolation and characterization of circulating immune complexes in cystic fibrosis. Clin. Exp. Immunol. 1982; 47: 301
   PubMedGoogle Scholar
• King T. E., Schwartz M. I., Dreisin R. E., Pratt D. S., Theofilopoulos A. N. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann. Intern. Med. 1979; 91: 397
   PubMed Web of Science ®Google Scholar
• Miossec P., Youinou P., Cledes J., Clavier J., Philippon P., Ferec C., Casburn-Budd R. Lowered Fc IgG receptor-bearing T lymphocytes correlate with non-organ-specific autoantibodies in silicosis. Int. Arch. Allergy Appl. Immunol. 1984; 73: 212
   PubMedGoogle Scholar
• Kuramoto M., Okamura K., Hamazaki Y., Furukawa K., Suzuki M. The role of circulating immune complexes in pregnancy. Tohoku J. Exp. Med. 1982; 138: 7
   PubMedGoogle Scholar
• Pope R. M., Yoshinoya S., Rutstein J., Persellin R. H. Effect of pregnancy on immune complexes and rheumatoid factors in patients with rheumatoid arthritis. Amer. J. Med. 1983; 74: 973
   PubMed Web of Science ®Google Scholar
• Westergaard J. G., Svahag S. E., Hau J., Teisner B. Quantitative comparison of circulating immune complexes in normal pregnancy and pregnancy related hypertension. Acta. Obstet. Gynecol. Scand. 1986; 65: 181
   PubMed Web of Science ®Google Scholar
• Alexander N. J., Fulgham D. L., Plunkett E. R., Witkin S. S. Antisperm antibodies and circulating immune complexes of vasectomized men with and without coronary events. Amer. J. Reprod. Immunol. Microbiol. 1986; 12: 38
   PubMedGoogle Scholar
• Smith M. D., Verrousi P. J., Griffin P. J. A., Salaman J. R. The detection of circulating immune complexes in renal transplant patients. Clin. Exp. Immunol. 1980; 39: 141
   PubMedGoogle Scholar
• Fearon D. R., Daha M. R., Strom T. B., Weller J. M., Carpenter C. B., Austen K. F. Pathways of complement activation in membrane proliferative glomerulonephritis and allograft rejection. Transplant. Proc 1977; 9: 729
   PubMed Web of Science ®Google Scholar
• Ooi Y. M., Ooi B. S., Vallota E. H., First M. R., Pollak V. E. Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney. J. Clin. Invest. 1977; 60: 611
   PubMed Web of Science ®Google Scholar
• Bielory L., Gasoon P., Lawley T. J., Nienhuis A., Frank M. M., Young N. S. Serum sickness and haematopoietic recovery with antithymocyte globulin in bone marrow failure patients. Brit. J. Haematol. 1986; 63: 729
   PubMedGoogle Scholar
• Frank M. M. Complement in the pathophysiology of human disease. N. Engl. J. Med. 1987; 316: 1525
   PubMed Web of Science ®Google Scholar
• Mannik M. Pathophysiology of circulating immune complexes. Arth. Rheum. 1982; 25: 783
   PubMedGoogle Scholar